Business - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended				6 Months Ended
	Jun. 01, 2021	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Jan. 31, 2022	Dec. 31, 2021
Class Of Stock [Line Items]
Proceeds from initial public offering, net of issuance costs						$ 0	$ 238,644
Convertible Preferred Stock, Shares Issued upon Conversion		38,826,388				38,826,388
Accumulated deficit		$ (197,884)				$ (197,884)			$ (151,896)
Net loss		(23,982)	$ (22,006)	$ (37,479)	$ (23,921)	(45,988)	$ (61,400)
Cash Cash Equivalents And Short Term Investments		$ 287,500				$ 287,500
Period of operations sufficient to fund						12 months
Common Stock
Class Of Stock [Line Items]
Stock Issued During Period Shares New Issues				11,730,000
Conversion of convertible securities				7,531,777
Convertible Preferred Stock
Class Of Stock [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion								1,000
IPO
Class Of Stock [Line Items]
Stock Issued During Period Shares New Issues	11,730,000
Shares Issued, Price Per Share	$ 22.00
IPO | Convertible Debt | 2021 Notes
Class Of Stock [Line Items]
Conversion of convertible securities	7,531,777
IPO | Convertible Preferred Stock
Class Of Stock [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion	38,826,388
IPO | Convertible Preferred Stock | Common Stock
Class Of Stock [Line Items]
Outstanding warrant to purchase convertible preferred stock	129,156
Singular Genomics Systems
Class Of Stock [Line Items]
Proceeds from initial public offering, net of issuance costs						$ 237,200
Payments for Underwriting Expense						$ 20,900
Singular Genomics Systems | Over-Allotment Option
Class Of Stock [Line Items]
Stock Issued During Period Shares New Issues						1,530,000